KALOWSKI LEE (CFO and President) sold 10.0% of their position (4K shares) of Q32 BIO INC. on the open market
Open‑market sale worth $18.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/27/2026ACC: 0001193125-26-083588
Officer· CFO and President
Since Feb 2026
-4K
Net shares
Net seller
$18.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$4.51
Trade value
$18.04K
% of position
10.0%
2/25/2026
39.94K→35.94K
Total
Net shares
−4K
Net value
-$18.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2026 | S · Sale | −4K | $4.51 | $18.04K | 10.0% | 39.94K | 35.94K |
| Total | −4K | -$18.04K | ||||||
Derivative Transactions0
No derivative transactions reported